Legislative Research: US HB8190 | 2019-2020 | 116th Congress
Other Sessions
Session | Title/Description | Last Action |
---|---|---|
2021-2022 117th Congress (Introduced - Dead) | To amend the Internal Revenue Code of 1986 to treat certain assisted reproduction expenses as medical expenses of the taxpayer. [HB8190 2021 Detail][HB8190 2021 Text][HB8190 2021 Comments] | 2022-06-22 Referred to the House Committee on Ways and Means. |
2019-2020 116th Congress (Introduced - Dead) | To amend the Public Health Service Act to deem any insulin that is determined by the Secretary to be biosimilar to the reference product to be interchangeable with the reference product, and for other purposes. [HB8190 2019 Detail][HB8190 2019 Text][HB8190 2019 Comments] | 2020-09-16 Sponsor introductory remarks on measure. (CR H4487) |
References Online
Search Phrase | Web | News | Financial | Financial | Encylopedia | Biography | BioGuide |
---|---|---|---|---|---|---|---|
[US Congress HB8190] | Google Web | Google News | |||||
[Representative Glenn Grothman US] | Google Web | Google News | OpenSecrets | FollowTheMoney | Ballotpedia | VoteSmart | BioGuide |
[Representative Michael San Nicolas US] | Google Web | Google News | N/A | N/A | Ballotpedia | VoteSmart | BioGuide |
Legislative Citation
APA
US HB8190 | 2019-2020 | 116th Congress. (2020, September 16). LegiScan. Retrieved April 29, 2024, from https://legiscan.com/US/bill/HB8190/2019
MLA
"US HB8190 | 2019-2020 | 116th Congress." LegiScan. LegiScan LLC, 16 Sep. 2020. Web. 29 Apr. 2024. <https://legiscan.com/US/bill/HB8190/2019>.
Chicago
"US HB8190 | 2019-2020 | 116th Congress." September 16, 2020 LegiScan. Accessed April 29, 2024. https://legiscan.com/US/bill/HB8190/2019.
Turabian
LegiScan. US HB8190 | 2019-2020 | 116th Congress. 16 September 2020. https://legiscan.com/US/bill/HB8190/2019 (accessed April 29, 2024).
Subjects
Blood and blood diseases
Competition and antitrust
Drug safety, medical device, and laboratory regulation
Drug therapy
Health
Health technology, devices, supplies
Intellectual property
Licensing and registrations
Prescription drugs
Competition and antitrust
Drug safety, medical device, and laboratory regulation
Drug therapy
Health
Health technology, devices, supplies
Intellectual property
Licensing and registrations
Prescription drugs
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/house-bill/8190/all-info |
Text | https://www.congress.gov/116/bills/hr8190/BILLS-116hr8190ih.pdf |